Inventiva announces the closing of $107.7 million initial public offering on the Nasdaq Global Market

    NEXT STORY
    Aptose Announces Proposed Public Offering of Common Shares
    PREV STORY
    National Organization for Victim Assistance and R3 Continuum Announce New Partnership
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TG Therapeutics, Inc. Announces Clinical Data Presentation at the Upcoming 52nd Annual Meeting of the American Society of Clinical Oncology

    NEW YORK, May 18, 2016 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), today announced ...

    author_avatar
    NASDAQ Market News

    AstraZeneca completes agreement with Tillotts Pharma for Entocort

    AstraZeneca today announced that it has completed its agreement with Tillotts Pharma AG (Tillotts), ...

    author_avatar
    NASDAQ Market News

    Versartis’ Long-Acting Somavaratan for Growth Hormone Deficiency to be Featured in Multiple Oral and Poster Presentations at ENDO 2017

    36-month data in pediatric GHD, showing consistent safety and efficacy profile through 3 years ...

    author_avatar
    NASDAQ Market News